Atossa Therapeutics Inc logo

Atossa Therapeutics Inc

2
NAS:ATOS (USA)  
$ 1.67 -0.11 (-6.21%) 10:08 PM EST
At Loss
P/B:
2.27
Market Cap:
$ 209.26M
Enterprise V:
$ 132.70M
Volume:
1.97M
Avg Vol (2M):
1.98M
Also Trade In:
Volume:
1.97M
At Loss
Avg Vol (2M):
1.98M

Business Description

Description
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.95
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 35.19
9-Day RSI 46.14
14-Day RSI 52.04
6-1 Month Momentum % 96.99
12-1 Month Momentum % 81.69

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 17.61
Quick Ratio 17.61
Cash Ratio 16.89

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -37.6

Financials (Next Earnings Date:2024-05-15 Est.)

ATOS's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ATOS

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Atossa Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.24
Beta 1.55
Volatility % 108.27
14-Day RSI 52.04
14-Day ATR ($) 0.206221
20-Day SMA ($) 1.752
12-1 Month Momentum % 81.69
52-Week Range ($) 0.5901 - 2.31
Shares Outstanding (Mil) 125.3

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Atossa Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Atossa Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Atossa Therapeutics Inc Frequently Asked Questions

What is Atossa Therapeutics Inc(ATOS)'s stock price today?
The current price of ATOS is $1.67. The 52 week high of ATOS is $2.31 and 52 week low is $0.59.
When is next earnings date of Atossa Therapeutics Inc(ATOS)?
The next earnings date of Atossa Therapeutics Inc(ATOS) is 2024-05-15 Est..
Does Atossa Therapeutics Inc(ATOS) pay dividends? If so, how much?
Atossa Therapeutics Inc(ATOS) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1